Sunbelt Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Sell
5,741
-15,575
-73% -$738K 0.01% 629
2025
Q4
$1.08M Buy
21,316
+323
+2% +$16.5K 0.07% 225
2025
Q3
$1.16M Buy
20,993
+7,764
+59% +$454K 0.08% 210
2025
Q2
$1.14M Sell
13,229
-3,387
-20% -$230K 0.1% 185
2025
Q1
$1.15M Buy
16,616
+3,387
+26% +$280K 0.1% 172
2024
Q4
$1.13M Buy
13,229
+643
+5% +$69.5K 0.1% 185
2024
Q3
$1.5M Buy
12,586
+1,834
+17% +$245K 0.15% 143
2024
Q2
$1.53M Buy
10,752
+138
+1% +$18.3K 0.16% 128
2024
Q1
$1.36M Sell
10,614
-1,813
-15% -$216K 0.15% 138
2023
Q4
$1.29M Sell
12,427
-152
-1% -$15K 0.16% 143
2023
Q3
$1.14M Buy
12,579
+239
+2% +$21.1K 0.16% 147
2023
Q2
$998K Buy
12,340
+500
+4% +$40.8K 0.14% 157
2023
Q1
$936K Sell
11,840
-3,284
-22% -$233K 0.15% 151
2022
Q4
$1.02M Sell
15,124
-198
-1% -$11.6K 0.2% 132
2022
Q3
$763K Buy
15,322
+870
+6% +$46.6K 0.16% 161
2022
Q2
$805K Sell
14,452
-5,612
-28% -$311K 0.17% 149
2022
Q1
$1.13M Sell
20,064
-702
-3% -$36K 0.21% 125
2021
Q4
$1.05M Sell
20,766
-566
-3% -$30.7K 0.17% 141
2021
Q3
$946K Hold
21,332
0.17% 143
2021
Q2
$946K Buy
21,332
+26
+0.1% +$1.01K 0.17% 143
2021
Q1
$718K Sell
21,306
-1,820
-8% -$64.8K 0.14% 182
2020
Q4
$808K Sell
23,126
-814
-3% -$28.1K 0.17% 149
2020
Q3
$831K Sell
23,940
-1,002
-4% -$33.4K 0.23% 112
2020
Q2
$817K Sell
24,942
-131,498
-84% -$4.2M 0.28% 99
2020
Q1
$4.66M Buy
156,440
+116,488
+292% +$3.47M 0.2% 63
2019
Q4
$955K Buy
39,952
+6,820
+21% +$189K 0.1% 205
2019
Q3
$856K Buy
33,132
+7,214
+28% +$182K 0.1% 205
2019
Q2
$661K Buy
25,918
+476
+2% +$11.8K 0.29% 103
2019
Q1
$665K Buy
25,442
+1,458
+6% +$35.8K 0.33% 86
2018
Q4
$552K Buy
23,984
+1,930
+9% +$42.9K 0.32% 87
2018
Q3
$520K Buy
22,054
+28
+0.1% +$683 0.28% 101
2018
Q2
$508K Buy
22,026
+4,648
+27% +$110K 0.3% 93
2018
Q1
$428K Sell
17,378
-13,692
-44% -$359K 0.39% 83
2017
Q4
$834K Sell
31,070
-42
-0.1% -$1.07K 0.81% 26
2017
Q3
$749K Sell
31,112
-946
-3% -$21.4K 0.79% 31
2017
Q2
$687K Sell
32,058
-232
-0.7% -$4.68K 1.29% 19
2017
Q1
$553K Buy
32,290
+9,504
+42% +$165K 0.83% 27
2016
Q4
$409K Sell
22,786
-11,448
-33% -$208K 0.62% 38
2016
Q3
$712K Buy
34,234
+22,464
+191% +$557K 0.86% 23
2016
Q2
$316K Buy
+11,770
New +$323K 0.41% 57

Other funds holding NVO

Sunbelt Securities's NVO Position: Q1 2026 in Review

Sunbelt Securities reduced its Novo Nordisk (NVO) stake by 73% in Q1 2026, selling an estimated $738K and leaving 5,741 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #629.

Sunbelt Securities first reported a position in NVO in Q2 2016 and has held it in 40 quarters since. The position peaked at $4.66M in Q1 2020. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Sunbelt Securities held 5,741 shares of Novo Nordisk worth $211K as of Q1 2026.
  • Sunbelt Securities sold 15,575 Novo Nordisk shares in Q1 2026, an estimated $738K.
  • Novo Nordisk made up 0.01% of Sunbelt Securities's portfolio in Q1 2026, its #629 holding.
  • Sunbelt Securities first reported a position in Novo Nordisk in Q2 2016 and has held it in 40 quarters since.
  • Sunbelt Securities's Novo Nordisk position peaked at $4.66M in Q1 2020.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.